Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3105 results found
Expand All
Apply All
3105 results found

Why “Tiger King” is more than a pandemic distraction
Share
Good Day BIO Newsletter  •  May 26, 2020
We’re starting a short but busy week with a new episode of the I AM BIO Podcast about why “Tiger King” couldn’t have come at a better time. (And it’s not what you think.) And did you have a socially distanced barbecue yesterday? We take a look at how biotech may have made your food healthier and taste better. Here’s today’s news in 800 words, about 4 minutes.
Read More

The Bayh-Dole Act and the race to eradicate COVID-19
Share
Good Day BIO Newsletter  •  May 22, 2020
Before you move from the home office to the backyard for the long weekend, read up on this important law that’s making breakthrough treatments possible, in around 670 words, or 3 minutes, 20 seconds. Good Day BIO is taking a quick break for Memorial Day. We’ll be in touch if there’s major breaking news, but otherwise, we’ll resume regular publication on Tuesday, May 26.
Read More

A step toward a stronger bioeconomy
Share
Good Day BIO Newsletter  •  May 21, 2020
Even with #WFH, there’s still a lot happening on Capitol Hill—and yesterday, a Senate Committee took an important step forward for the bioeconomy. More on that, plus an update from Jim on how the SEC is providing relief to small biotechs on the COVID-19 frontlines, in around 720 words, under 4 minutes.
Read More

On vaccine manufacturing, distribution, and hope
Share
Good Day BIO Newsletter  •  May 20, 2020
Lots of questions today—on vaccine manufacturing and distribution, on whether we should get excited (yet) about potential vaccine candidates, and on whether bats are to blame for the pandemic. We have some answers, as well as the latest news from Washington (there's a lot!) in around 900 words, 4 minutes, 30 seconds.
Read More

BBC is bringing biotech to the fall lineup
Share
Good Day BIO Newsletter  •  May 19, 2020
It’s a busy Tuesday, and we’ve got a quick hit today, with around 500 words (2 and a half minutes) on an exciting new project with the BBC and what you might have missed in Washington.
Read More

Patient Support Programs
Share
Policy

The biotech looking for “the Michael Jordan of antibodies”
Share
Good Day BIO Newsletter  •  May 18, 2020
We’re kicking off the week with a fascinating new episode of the I AM BIO Podcast about one company searching for a superstar antibody that could help us understand and beat COVID-19. And we’ve also got more from Cargill and Capitol Hill. Here’s your Monday news, in 880 words, about 4 minutes, 20 seconds.
Read More

Food and Drug Administration Expedited Approval Programs
Share
Human Health, Legislation  •  Toolkit  •  May 18, 2020
The goal of expedited approval pathways is to provide safe and effective therapies for serious, unmet medical needs as quickly as possible.
Read More

We've got the dirt on USDA’s final rule on plant biotech
Share
Good Day BIO Newsletter  •  May 15, 2020
It’s Friday, but we’ve got a jam-packed issue today: news on USDA’s new rule on food biotech, a new resource for learning about global COVID-19 collaborations, plus two must-watch videos. Here are just under 1,000 words, just under 5 minutes. P.S. Don’t miss the latest episode of the I AM BIO Podcast featuring Christi Shaw, CEO of Kite, Gilead’s cell therapy company, about CAR T and why “cancer doesn’t stop in the crisis.” Listen at www.bio.org/podcast or wherever you get your podcasts.
Read More

Modernized Biotech Regulation Will Unleash Greater Innovation
Share
Agriculture & Environment, Food & Farm Innovation  •  Press Release  •  May 14, 2020
The U.S. Department of Agriculture (USDA) released today a modernized, science-based regulatory system for plant biotechnology aimed at maintaining oversight while driving innovation. Now government and industry must do more to build an informed and trust-based dialogue about biotechnology innovation in food and agriculture and its potential to achieve greater outcomes for the planet, our food system and human well-being, says the Biotechnology Innovation Organization (BIO).           While BIO is still reviewing the details of the final rule, the following statement may be attributed to Dana O’Brien, executive vice president of BIO’s food & agriculture section: “Biotechnology is key to building more resilient food and farming systems. The COVID-19 crisis shows us the fragility of these systems and shines a bright light on the essential role of biology and technology in our lives. The rule released by USDA today will accelerate the development of innovations that will improve lives globally. “BIO is pleased that USDA’s updated regulatory approach builds on decades of scientific knowledge about biotechnology in food and agriculture. It holds great promise to enhance investment and product development by small and mid-sized companies in particular. “Innovation flourishes when science and consumer values are aligned and complement one another. The U.S. government’s regulatory approach cannot exist in isolation. It should be supported by credible transparency measures. BIO understands that consumers want more information about what is in their food and whether their food is safe. Our members will be a driver of that endeavor.” During the public comment period, BIO advocated for a process to improve public access to information about new agricultural biotechnology products. While the final rule does not contain a mechanism for mandatory notification, BIO encourages increased openness about products entering…
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 224
  • 225
  • 226
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO